Clinical Trials · NCT02788578
A Retrospective Data Analysis of Therapy With PRRT Combined With Lanreotide Autogel® for Neuroendocrine Tumours
- Phase
- N/A
- Recruitment status
- Terminated
- Sponsor
- Ipsen
- Enrollment
- 40
- Start date
- Jun 2016
- Locations
- 12 sites, 5 countries
- Primary endpoint
- Progression Free Survival (PFS) rate according to the central reading using RECIST (Version 1.1)